Page 26 - Risk Management Bulletin February 2024
P. 26

RMAI BULLETIN FEBRUARY 2024


             can contribute to reducing the risk of transmission.  The ambiguity surrounding the duration and se-
             Additionally, increased testing capacity plays a crucial  verity of the pandemic makes it challenging to
             role in promptly identifying and isolating COVID-19  plan and implement effective economic recovery
             positive cases, thereby mitigating secondary infections  strategies.
             through stricter quarantine protocols.           6) Social Impacts: COVID-19 has disrupted social in-
                                                                 teractions, including limitations on gatherings,
             In summary, the ongoing global pandemic necessitates  travel restrictions, and remote work arrange-
             a multifaceted approach centred around prevention   ments. The ambiguity surrounding the duration of
             and containment measures. While no specific medica-  these measures and their impact on mental
             tion has been approved to date, the collective adop-  health, social cohesion, and community well-be-
             tion of preventive actions, along with robust testing  ing poses challenges in maintaining social stabil-
             and quarantine strategies, remains the most effective  ity and support.
             means of combating the impact of COVID-19 on pub-
                                                              7) Vaccine Distribution and Prioritization: The dis-
             lic health, economies, politics, and societal well-being.
                                                                 tribution and prioritization of COVID-19 vaccines
                                                                 present challenges due to limited global supply
             Key Highlights of Emergency Risks on                and varying national strategies. Determining who
             COVID 19: -                                         should receive the vaccine first, ensuring equitable
             1) Evolving Scientific Understanding: The constantly  access, and addressing vaccine hesitancy are com-
                 evolving scientific understanding of COVID-19 pre-  plex issues that require careful consideration.
                 sents a challenge in effectively responding to the  8) Infodemic and Misinformation: The infodemic
                 pandemic. As new research emerges, recommen-    characterized by the rapid spread of misinforma-
                 dations and guidelines may change, leading to   tion and conspiracy theories, poses risks to public
                 confusion and uncertainty among the general     health efforts. False information regarding COVID-
                 public and healthcare professionals.            19 prevention, treatment, and vaccines can hinder
                                                                 compliance with recommended measures and
             2) Diagnostic Challenges: Accurate and timely diag-
                                                                 contribute to the spread of the virus.
                 nosis of COVID-19 is crucial for effective contain-
                 ment measures. However, challenges related to  9) Vaccine Development and Efficacy: While vac-
                 testing availability, accuracy, and interpretation of  cines have been developed and deployed against
                 results can impact the identification and tracking  COVID-19, questions about their long-term effi-
                 of cases, hindering outbreak control efforts.   cacy, potential side effects, and response to
                                                                 emerging variants remain. Monitoring vaccine ef-
             3) Asymptomatic Transmission: The ability of
                                                                 fectiveness and addressing public concerns is vi-
                 COVID-19 to spread through asymptomatic indi-   tal for maintaining trust and confidence in vacci-
                 viduals poses a significant risk. People who are  nation efforts.
                 infected but show no symptoms can unknowingly
                                                              10) Global Cooperation and Coordination: COVID-19
                 transmit the virus, making it challenging to iden-
                 tify and control the spread of the disease.     is a global crisis that requires international coop-
                                                                 eration and coordination. Ambiguity surrounding
             4) Healthcare System Strain: The overwhelming       geopolitical dynamics, information sharing, and re-
                 number of COVID-19 cases can strain healthcare  source allocation can hinder effective collabora-
                 systems, leading to shortages of beds, medical  tion, potentially impacting global efforts to control
                 supplies, and healthcare professionals. This strain  the pandemic.
                 can result in compromised care for COVID-19 pa-
                 tients as well as individuals with other medical  Conclusion
                 conditions.
                                                              Emerging risks are unpredictable and novel risks that
             5) Economic Impact: The pandemic has had far-    have the potential to cause significant harm and loss.
                 reaching economic consequences, including busi-  They require specific strategies and approaches for
                 ness closures, job losses, and financial instability.  identification and management.


                                                           24
   21   22   23   24   25   26   27   28   29   30   31